JAK inhibitor treatment-resistant splenomegaly before transplantation in myelofibrosis: Splenectomy or radiotherapy?

Am J Hematol. 2024 May;99(5):804-805. doi: 10.1002/ajh.27292. Epub 2024 Mar 14.

Authors

Maria Chiara Finazzi¹, Ayalew Tefferi^{2

3}, Alessandro Rambaldi^{1

2

3

4}

Affiliations

¹ Azienda Socio-Sanitaria Territoriale Papa Giovanni XXIII Piazza OMS, Bergamo, Italy.
² Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
³ Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
⁴ Department of Oncology and Hematology, University of Milan, Milan, Italy.

PMID: 38482991
DOI: 10.1002/ajh.27292

No abstract available

Publication types

Editorial

MeSH terms

Hematopoietic Stem Cell Transplantation*
Humans
Janus Kinase Inhibitors*
Primary Myelofibrosis* / therapy
Splenectomy
Splenomegaly

Substances

Janus Kinase Inhibitors